Profil bibliographique

Mathis Thoma

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

37Publications signalées

484Citations signalées

0Affiliations récentes

Les domaines associés

Multiple Sclerosis Research StudiesCarcinogens and Genotoxicity AssessmentPharmacogenetics and Drug MetabolismGenetic Associations and EpidemiologyStatistical Methods in Clinical Trials

Les publications récentes

Accès ouvert 2024 article OpenAlex

DKN-01 in Combination With Tislelizumab and Chemotherapy as First-Line Therapy in Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: DisTinGuish

Samuel J. Klempner, Mohamad Bassam Sonbol, Zev A. Wainberg, Hope E. Uronis et autres

us (code pays fourni par la source)

34 citations Journal of Clinical Oncology

Accès ouvert 2023 conference-abstract OpenAlex

A phase 2 study (DisTinGuish) of DKN-01 in combination with tislelizumab + chemotherapy as first-line (1L) therapy in patients with advanced gastric or GEJ adenocarcinoma (GEA).

Samuel J. Klempner, Bassam Bassam Sonbol, Zev A. Wainberg, Hope E. Uronis et autres

us (code pays fourni par la source)

14 citations Journal of Clinical Oncology

Accès ouvert 2017 article OpenAlex

A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosis

Colin J.D. Ross, Fadi Towfic, Jyoti Shankar, Daphna Laifenfeld et autres

ca, us, il (code pays fourni par la source)

27 citations Genome Medicine

Accès ouvert 2017 article OpenAlex

Additional file 8: of A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosis

Colin Ross, Fadi Towfic, Jyoti Shankar, Daphna Laifenfeld et autres

0 citations Figshare

Accès ouvert 2017 article OpenAlex

Additional file 1: of A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosis

Colin Ross, Fadi Towfic, Jyoti Shankar, Daphna Laifenfeld et autres

0 citations Figshare

Accès ouvert 2017 article OpenAlex

Additional file 10: of A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosis

Colin Ross, Fadi Towfic, Jyoti Shankar, Daphna Laifenfeld et autres

0 citations Figshare

Accès ouvert 2017 article OpenAlex

Additional file 11: of A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosis

Colin Ross, Fadi Towfic, Jyoti Shankar, Daphna Laifenfeld et autres

0 citations Figshare

Accès ouvert 2017 article OpenAlex

Additional file 2: of A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosis

Colin Ross, Fadi Towfic, Jyoti Shankar, Daphna Laifenfeld et autres

0 citations Figshare

Accès ouvert 2017 article OpenAlex

Additional file 9: of A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosis

Colin Ross, Fadi Towfic, Jyoti Shankar, Daphna Laifenfeld et autres

0 citations Figshare

Accès ouvert 2017 article OpenAlex

Additional file 3: of A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosis

Colin Ross, Fadi Towfic, Jyoti Shankar, Daphna Laifenfeld et autres

0 citations Figshare

Accès ouvert 2017 article OpenAlex

Additional file 12: of A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosis

Colin Ross, Fadi Towfic, Jyoti Shankar, Daphna Laifenfeld et autres

0 citations Figshare

Accès ouvert 2017 article OpenAlex

Additional file 4: of A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosis

Colin Ross, Fadi Towfic, Jyoti Shankar, Daphna Laifenfeld et autres

0 citations Figshare

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.